# PTP4A2

## Overview
PTP4A2, also known as PRL-2, is a gene that encodes the protein tyrosine phosphatase 4A2, a member of the protein tyrosine phosphatase (PTP) family. This family of enzymes is involved in the regulation of a variety of cellular processes by dephosphorylating tyrosine residues on target proteins. The protein tyrosine phosphatase 4A2 is primarily associated with cellular signaling pathways that influence cell survival, proliferation, and migration. It plays a significant role in the PI3K/Akt signaling pathway, impacting processes such as spermatogenesis, hematopoietic stem cell proliferation, and T cell development (Hardy2018Physiological). Additionally, PTP4A2 is crucial for vascular development and angiogenesis, particularly in the nervous system (Poulet2020PRL2). The protein is active in the cytoplasm and associated with the plasma membrane, where it influences cellular dynamics and has been implicated in cancer progression and metastasis (Andres2013Protein).

## Structure


## Function
PTP4A2, also known as PRL-2, is a protein tyrosine phosphatase involved in several cellular processes. In healthy human cells, PRL-2 plays a role in promoting cell survival through the SCF/Kit-mediated PI3K/Akt signaling pathway, potentially by downregulating PTEN. This activity is crucial during processes such as spermatogenesis, hematopoietic stem cell proliferation, and T cell development (Hardy2018Physiological). PRL-2 is also implicated in regulating magnesium homeostasis, influencing cellular magnesium flux, which impacts energy metabolism (Hardy2018Physiological).

PRL-2 is predominantly expressed in endothelial cells, where it is essential for vascular development and angiogenesis, particularly in the nervous system, including the retina. Its expression is enriched in capillary, venous, and mitotic endothelial cells, and its deletion results in impaired vascular development and increased vascular regression (Poulet2020PRL2). Additionally, PRL-2 is involved in TGFβ signaling pathways in fibroblasts, contributing to the regulation of pro-fibrotic markers, although its specific role in healthy cells outside of fibrosis is less clear (Sacchetti2017PTP4A1).

PRL-2 is active in the cytoplasm and associated with the plasma membrane, influencing cellular dynamics and potentially impacting cancer progression and metastasis (Andres2013Protein).

## Clinical Significance
Alterations in the expression of the PTP4A2 gene, also known as PRL-2, have been implicated in various cancers, particularly breast cancer. Overexpression of PRL-2 is associated with enhanced tumor growth and progression in breast cancer, as it correlates with increased phosphorylation of ERK1/2, a pathway known to promote tumorigenesis (Hardy2010Overexpression). In human breast cancer specimens, PRL-2 expression is elevated in primary tumors and even more so in metastatic lymph nodes, suggesting its potential as a marker for breast cancer metastasis (Hardy2010Overexpression).

In addition to its role in breast cancer, PRL-2 is involved in vascular morphogenesis and angiogenic signaling. Knockout studies in mice have shown that loss of PTP4A2 leads to significant vascular defects, indicating its critical role in vascular development and stability (Poulet2020PRL2). These findings suggest that PTP4A2 may also be relevant in diseases involving vascular abnormalities.

In breast cancer, higher PTP4A2 expression has been linked to better overall and disease-free survival, particularly in estrogen receptor-positive or progesterone receptor-positive tumors, indicating its potential as a prognostic biomarker (Andres2013Protein).

## Interactions
PTP4A2, also known as PRL-2, is involved in several protein interactions that influence its role in cellular processes. One notable interaction is with the beta subunit of Rab geranylgeranyltransferase II, which suggests a regulatory role in its activity (Andres2013Protein). This interaction may contribute to the dual roles of PTP4A2 in different carcinomas, depending on the cellular context and stage of cancer progression.

PTP4A2 is also implicated in the ERK-dependent signaling pathway, which is crucial for tumor cell migration and invasion (Andres2013Protein). This pathway is significant in the context of breast cancer, where PTP4A2 overexpression correlates with increased ERK1/2 phosphorylation, promoting tumor growth and migration (Hardy2010Overexpression).

In the context of systemic sclerosis, PTP4A2 is involved in promoting TGFβ signaling, although it minimally interacts with SRC and does not significantly affect the SRC-ERK-SMAD3 pathway (Sacchetti2017PTP4A1). This suggests that PTP4A2 may have distinct roles in different signaling pathways, depending on the cellular environment and disease context.


## References


[1. (Hardy2010Overexpression) Serge Hardy, Nau Nau Wong, William J. Muller, Morag Park, and Michel L. Tremblay. Overexpression of the protein tyrosine phosphatase prl-2 correlates with breast tumor formation and progression. Cancer Research, 70(21):8959–8967, October 2010. URL: http://dx.doi.org/10.1158/0008-5472.can-10-2041, doi:10.1158/0008-5472.can-10-2041. This article has 57 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-10-2041)

[2. (Hardy2018Physiological) Serge Hardy, Elie Kostantin, Teri Hatzihristidis, Yevgen Zolotarov, Noriko Uetani, and Michel L. Tremblay. Physiological and oncogenic roles of the <scp>prl</scp> phosphatases. The FEBS Journal, 285(21):3886–3908, May 2018. URL: http://dx.doi.org/10.1111/febs.14503, doi:10.1111/febs.14503. This article has 42 citations.](https://doi.org/10.1111/febs.14503)

[3. (Sacchetti2017PTP4A1) Cristiano Sacchetti, Yunpeng Bai, Stephanie M. Stanford, Paola Di Benedetto, Paola Cipriani, Eugenio Santelli, Sonsoles Piera-Velazquez, Vladimir Chernitskiy, William B. Kiosses, Arnold Ceponis, Klaus H. Kaestner, Francesco Boin, Sergio A. Jimenez, Roberto Giacomelli, Zhong-Yin Zhang, and Nunzio Bottini. Ptp4a1 promotes tgfβ signaling and fibrosis in systemic sclerosis. Nature Communications, October 2017. URL: http://dx.doi.org/10.1038/s41467-017-01168-1, doi:10.1038/s41467-017-01168-1. This article has 42 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-017-01168-1)

[4. (Andres2013Protein) Sarah A. Andres, James L. Wittliff, and Alan Cheng. Protein tyrosine phosphatase 4a2 expression predicts overall and disease-free survival of human breast cancer and is associated with estrogen and progestin receptor status. Hormones and Cancer, 4(4):208–221, April 2013. URL: http://dx.doi.org/10.1007/s12672-013-0141-2, doi:10.1007/s12672-013-0141-2. This article has 11 citations.](https://doi.org/10.1007/s12672-013-0141-2)

[5. (Poulet2020PRL2) Mathilde Poulet, Jacinthe Sirois, Kevin Boyé, Noriko Uetani, Serge Hardy, Thomas Daubon, Alexandre Dubrac, Michel L. Tremblay, and Andreas Bikfalvi. Prl-2 phosphatase is required for vascular morphogenesis and angiogenic signaling. Communications Biology, October 2020. URL: http://dx.doi.org/10.1038/s42003-020-01343-z, doi:10.1038/s42003-020-01343-z. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-020-01343-z)